File A11256 ("Health plans must cover cheaper generic drugs") is before the New York Legislature and has not been decided. Latest step (May 4, 2026): In Assembly Committee.
New York file A11256, before the New York Legislature. Still to be decided as of 2026-05-04.
Lower out-of-pocket costs for prescription drugs If your doctor prescribes a brand-name drug but a cheaper generic or biosimilar alternative exists, your plan must cover the generic option, reducing your copays and deductibles.
Downward pressure on pharmaceutical pricing overall Mandating insurance coverage of lower-cost generics increases market demand for generic drugs, which can incentivize manufacturers to expand production and potentially accelerates generic entry into the market.
Limits physician prescribing discretion for brand drugs Doctors may face restrictions when they believe a brand-name drug is medically necessary; patients seeking specific brand drugs may need prior authorization or appeals, and some insurers warn this could delay access to preferred treatments.
Requires health plan coverage to include generic drugs and biosimilars where the wholesale acquisition cost of such generic drugs or biosimilars is lower than the brand drug's wholesale acquisition cost.
Read the official record for A11256
See everything up for a vote · This week in New York · See what we have filed with the clerk